Primary Myelofibrosis Completed Phase 2 Trials for Tipifarnib (DB04960)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00047190Tipifarnib in Treating Patients With Myelofibrosis and Myeloid MetaplasiaTreatment